Gerald J. Duke

机构：Bristol-Myers Squibb (United States)

发表论文 16 篇 · 总被引 474 次 · h-index 10

代表论文

• Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering (2014 · Journal of Pharmacology and Experimental Therapeutics · 被引 132)
• Structural basis for CARM1 inhibition by indole and pyrazole inhibitors (2011 · Biochemical Journal · 被引 100)
• Effects of the Prosegment and pH on the Activity of PCSK9 (2010 · Journal of Biological Chemistry · 被引 65)
• Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors (2008 · Bioorganic & Medicinal Chemistry Letters · 被引 31)
• Triazolopyrimidines identified as reversible myeloperoxidase inhibitors (2017 · MedChemComm · 被引 30)
• Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase (2020 · Bioorganic & Medicinal Chemistry · 被引 26)